CymitQuimica logo

CAS 138926-19-9

:

Ibandronate sodium monohydrate

Description:
Ibandronate sodium monohydrate is a bisphosphonate compound primarily used in the treatment of osteoporosis and other bone-related disorders. It functions by inhibiting osteoclast-mediated bone resorption, thereby helping to maintain or increase bone density. The substance appears as a white to off-white crystalline powder and is soluble in water, which facilitates its administration, typically via oral or intravenous routes. Its molecular formula includes a sodium ion and a monohydrate, indicating the presence of one water molecule per formula unit. Ibandronate sodium monohydrate has a relatively high affinity for hydroxyapatite, the mineral component of bone, which enhances its therapeutic efficacy. The compound is generally well-tolerated, although it may cause gastrointestinal side effects in some patients. Storage conditions typically require a cool, dry place to maintain stability. As with any medication, it is essential to follow prescribed dosages and consult healthcare professionals regarding potential interactions and contraindications.
Formula:C9H22NO7P2H2ONa
InChI:InChI=1/C9H23NO7P2.Na.H2O/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17;;/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17);;1H2/q;+1;/p-1
Synonyms:
  • [1-Hydroxy-3-(methylpentylamino)-propylidene]bisphosphonic acid sodium salt monohydrate
  • Sodium Hydrogen {1-Hydroxy-3-[Methyl(Pentyl)Amino]-1-Phosphonopropyl}Phosphonate Hydrate
  • [1-Hydroxy-3-(methylpentylamino)-propylidene]bisphosphonic acid sodium salt
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 11 products.